DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Weber JS, Kudchadkar RR, Yu B et al
Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma.
J Clin Oncol 2013;
31: 4311-4318
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.